Canadian Stroke Best Practice Guidance during the COVID-19 Pandemic

Eric E. Smith; Anita Mountain; Michael D. Hill; Theodore H. Wein; Dylan Blacquiere; Leanne K. Casaubon; Elizabeth Linkewich; Norine Foley; Gord Gubitz; Anne Simard; M. Patrice Lindsay

doi:10.1017/cjn.2020.74

Canadian Stroke Best Practice Guidance during the COVID-19 Pandemic

Eric E. Smith, Anita Mountain, Michael D. Hill, Theodore H. Wein, Dylan Blacquiere, Leanne K. Casaubon, Elizabeth Linkewich, Norine Foley, Gord Gubitz, Anne Simard, M. Patrice Lindsay

Medicine

Producción científica: Contribución a una revista › Comentario/debate › revisión exhaustiva

48 Citas (Scopus)

Idioma original	English
Páginas (desde-hasta)	474-478
Número de páginas	5
Publicación	Canadian Journal of Neurological Sciences
Volumen	47
N.º	4
DOI	https://doi.org/10.1017/cjn.2020.74
Estado	Published - jul. 1 2020

Nota bibliográfica

Funding Information:
AM reports involvement in clinical trial grants from Brain Canada, Heart and Stroke Foundation of Canada, and the Canadian Partnership for Stroke Recovery; MDH reports a relationship with NoNO Inc as an unpaid advisor, Boehringer-Ingelheim as a paid advisor, and holds research grants from CIHR, Alberta Innovates, Heart and Stroke Foundation of Canada, Heart and Stroke Foundation of Alberta, multiple industry partners for clinical trials managed through the University of Calgary; LKC participated in an advisory board for Bayer in 2018, and is an independent neurological assessor for patients in SURTAVI trial; GG is a collaborator in the ESCAPE-NA1 trial with the University of Calgary.

ASJC Scopus Subject Areas

Neurology
Clinical Neurology

Acceder al documento

10.1017/cjn.2020.74

Otros archivos y enlaces

Citar esto

@article{1e9eef551c544ae782d6301e74479b70,

title = "Canadian Stroke Best Practice Guidance during the COVID-19 Pandemic",

author = "Smith, {Eric E.} and Anita Mountain and Hill, {Michael D.} and Wein, {Theodore H.} and Dylan Blacquiere and Casaubon, {Leanne K.} and Elizabeth Linkewich and Norine Foley and Gord Gubitz and Anne Simard and Lindsay, {M. Patrice}",

note = "Funding Information: AM reports involvement in clinical trial grants from Brain Canada, Heart and Stroke Foundation of Canada, and the Canadian Partnership for Stroke Recovery; MDH reports a relationship with NoNO Inc as an unpaid advisor, Boehringer-Ingelheim as a paid advisor, and holds research grants from CIHR, Alberta Innovates, Heart and Stroke Foundation of Canada, Heart and Stroke Foundation of Alberta, multiple industry partners for clinical trials managed through the University of Calgary; LKC participated in an advisory board for Bayer in 2018, and is an independent neurological assessor for patients in SURTAVI trial; GG is a collaborator in the ESCAPE-NA1 trial with the University of Calgary. ",

year = "2020",

month = jul,

day = "1",

doi = "10.1017/cjn.2020.74",

language = "English",

volume = "47",

pages = "474--478",

journal = "Canadian Journal of Neurological Sciences",

issn = "0317-1671",

publisher = "Canadian Journal of Neurological Sciences",

number = "4",

}

TY - JOUR

T1 - Canadian Stroke Best Practice Guidance during the COVID-19 Pandemic

AU - Smith, Eric E.

AU - Mountain, Anita

AU - Hill, Michael D.

AU - Wein, Theodore H.

AU - Blacquiere, Dylan

AU - Casaubon, Leanne K.

AU - Linkewich, Elizabeth

AU - Foley, Norine

AU - Gubitz, Gord

AU - Simard, Anne

AU - Lindsay, M. Patrice

N1 - Funding Information: AM reports involvement in clinical trial grants from Brain Canada, Heart and Stroke Foundation of Canada, and the Canadian Partnership for Stroke Recovery; MDH reports a relationship with NoNO Inc as an unpaid advisor, Boehringer-Ingelheim as a paid advisor, and holds research grants from CIHR, Alberta Innovates, Heart and Stroke Foundation of Canada, Heart and Stroke Foundation of Alberta, multiple industry partners for clinical trials managed through the University of Calgary; LKC participated in an advisory board for Bayer in 2018, and is an independent neurological assessor for patients in SURTAVI trial; GG is a collaborator in the ESCAPE-NA1 trial with the University of Calgary.

PY - 2020/7/1

Y1 - 2020/7/1

UR - http://www.scopus.com/inward/record.url?scp=85086263426&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85086263426&partnerID=8YFLogxK

U2 - 10.1017/cjn.2020.74

DO - 10.1017/cjn.2020.74

M3 - Comment/debate

C2 - 32654680

AN - SCOPUS:85086263426

SN - 0317-1671

VL - 47

SP - 474

EP - 478

JO - Canadian Journal of Neurological Sciences

JF - Canadian Journal of Neurological Sciences

IS - 4

ER -